Abstract:Objective: As a new LncRNA, anti-differentiated non-coding RNA (DANCR) plays an important role in tumorigenesis and development, and its molecular mechanism in osteosarcoma is unclear. In this study, by investigating osteosarcoma tissue and cells, we explored the molecular mechanism by which lncRNA DANCR regulates the occurrence and development of osteosarcoma by targeting the miR-149 / MSI2 axis. Patients and methods: In this study, osteosarcoma tissues and adjacent tissues in 109 patients were collected, and the relative expression of DANCR was detected by qPCR. The correlation between DANCR expression and clinical classification was statistically analyzed. In order to explore the potential molecular mechanism of DANCR related to tumor migration and invasion, an overexpression and silencing test was performed on the osteosarcoma cell line Saos-2, and then qPCR method was used to test the expression of miR149, and cell scratch test was used to detect invasion after DANCR silencing and miR149 overexpression. Transwell assay was used to detect the invasion after DANCR silencing and miR149 overexpression. Finally, Western blot was used to verify the expression of MSI2 protein after overexpression and silencing of miR-149. Results: DANCR was significantly up-regulated in both osteosarcoma tissue and cells. The high expression of DANCR was significantly positively correlated with tissue typing and advanced TNM stage. DANCR can significantly reduce the migration and invasion of osteosarcoma cells. miRNA overexpression significantly reduced osteosarcoma cell migration and invasion. When miR-149 was overexpressed, MSI2 protein expression was significantly down-regulated. When miR-149 was silenced, MSI2 protein was significantly up-regulated. Conclusions: LncRNA DANCR plays an important regulatory role in the occurrence and development of osteosarcoma. It may be used as a potential target in the treatment of osteosarcoma in the future, by targeting the miR-149/MSI2 axis to regulate the occurrence and development of osteosarcoma.

Overexpression of lncRNA DANCR positively affects progression of glioma via activating Wnt/β-catenin signaling.

Long Noncoding RNA DANCR in Various Cancers: a Meta-Analysis and Bioinformatics.

LncRNA DANCR Functions As a Competing Endogenous RNA to Regulate RAB1A Expression by Sponging Mir-634 in Glioma

Long Non‑coding RNA LINC00473/miR‑195‑5p Promotes Glioma Progression Via YAP1‑TEAD1‑Hippo Signaling.

Long Non-Coding RNA DANCR Promotes Cervical Cancer Growth Via Activation of the Wnt/β-catenin Signaling Pathway

Over-expression of lncRNA DANCR is associated with advanced tumor progression and poor prognosis in patients with colorectal cancer.

LncRNA DANCR promotes tumor growth and angiogenesis in ovarian cancer through direct targeting of miR-145.

DANCR Promotes Metastasis and Proliferation in Bladder Cancer Cells by Enhancing IL-11-STAT3 Signaling and CCND1 Expression.

Long Non‑coding RNA DANCR Promotes Nasopharyngeal Carcinoma Cell Proliferation and Migration.

IGF2BP2 Regulates DANCR by Serving As an N6-methyladenosine Reader.

LncRNA DANCR Enhances Angiogenesis to Promote Melanoma Progression Via Sponging miR-5194

Long Non-Coding RNA LINC01503 Predicts Worse Prognosis in Glioma and Promotes Tumorigenesis and Progression Through Activation of Wnt/β-catenin Signaling.

LncRNA differentiation antagonizing non-protein coding RNA promotes proliferation and invasion through regulating miR-135a/NLRP37 axis in pancreatic cancer

Long Non-coding RNA DANCR in Cancer: Roles, Mechanisms, and Implications

Long Noncoding RNA DANCR Increases Stemness Features of Hepatocellular Carcinoma by Derepression of CTNNB1.

Long non‐coding RNA DANCR aggravates breast cancer through the miR‐34c/E2F1 feedback loop

New evidence for a role of DANCR in cancers: a comprehensive review

Long Non-Coding RNA DANCR Promotes Malignant Phenotypes of Bladder Cancer Cells by Modulating the Mir-149/Msi2 Axis As a Cerna.

LncRNA DANCR regulates osteosarcoma migration and invasion by targeting miR-149/MSI2 axis

Long Non-coding RNA DANCR As an Emerging Therapeutic Target in Human Cancers

Overexpression of Long Non-Coding RNA Differentiation Antagonizing Non-Protein Coding RNA Inhibits the Proliferation, Migration and Invasion and Promotes Apoptosis of Renal Cell Carcinoma.